The 32 references in paper M. ZHELYAZKOVA-SAVOVA D., B. GALUNSKA Tz., D. GEROVA I., T. CHERVENKOV G., M. SIDEROVA V., R. ZORCHEVA J., D. PASKALEV N., М. ЖЕЛЯЗКОВА-САВОВА Д., Б. ГАЛУНСКА Т., Д. ГЕРОВА И., Т. ЧЕРВЕНКОВ Г., М. СИДЕРОВА В., Р. ЗОРЧЕВА Ж., Д. ПАСКАЛЕВ Н. (2011) “НЕКАРБОКСИЛИРОВАННЫЙ ОСТЕОКАЛЬЦИН У ЖЕНЩИН В ПОСТМЕНОПАУЗЕ, ПОЛУЧАЮЩИХ ЛЕЧЕНИЕ ГЕМОДИАЛИЗОМ // UNDERCARBOXYLATED OSTEOCALCIN IN POSTMENOPAUSAL PATIENTS ON HEMODIALYSIS” / spz:neicon:nefr:y:2011:i:3:p:35-39

1
Oldenburg J, Marinova M, Muller-Reible C, Watzka M. In: Litwack G, ed. Vitamin K. Academic Press, Elsevier, 2008; 46
(check this in PDF content)
2
Price PA, Parthemore JG and Deftos LJ. New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease. J Clin Invest 1980, 66, 878-83
(check this in PDF content)
3
Urena P, de Vernejoul M. Circulating biochemical markers of bone remodeling in uremic patients. Kidney Int 1999; 55:21412156
(check this in PDF content)
4
Brown JP, Delmas PD, Malaval L, Edouard C et al. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet 1984; 1(8386):1091-1093
(check this in PDF content)
5
Ivaska K. Osteocalcin. Novel insights into the use of osteocalcin as a determinant of bone metabolism. PhD thesis, 2005:26
(check this in PDF content)
6
Adams J, Pepping J. Vitamin K in the treatment and prevention of osteoporosis and arterial calcification. Am J Health-Syst Pharm 2005; 62(15):1574-1581
(check this in PDF content)
7
Feskanich D, Weber P, Willett WC, Rockett H et al.Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr 1999; 69(1):74-79
(check this in PDF content)
8
Plantalech L, Guillaumont M, Vergnaud P, Leclercq M et al. Impairment of gamma carboxylation of circulating osteocalcin (bone gla protein) in elderly women. J Bone Miner Res 1991; 6(11):1211-1216
(check this in PDF content)
9
Vermeer C, Hamulyak K. Pathophysiology of vitamin Kdeficiency and oral anticoagulants. Thromb Haemost 1991; 66:153-159
(check this in PDF content)
10
Kim SM, Kim KM, Kim BT, Joo NS et al. Correlation of undercarboxylated osteocalcin (ucOC) concentration and bone density with age in healthy Korean women. J Korean Med Sci 2010; 25(8):1171-1175
(check this in PDF content)
11
Szulc P, Arlot M, Chapuy MC, Duboeuf F et al. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone MinerRes 1994; 9:1591-1595
(check this in PDF content)
12
Arunakul M, Niempoog S, Arunakul P, Bunyaratavej N. Level of undercarboxylated osteocalcin in hip fracture Thai female patients. J Med Assoc Thai 2009; 92 [suppl 5]:S7-11
(check this in PDF content)
13
Vergnaud P, Garnero P, Meunier PJ, Breart G et al. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997; (3):719-724
(check this in PDF content)
14
Vermeer C, Shearer MJ, Zittermann A, Bolton-Smith C et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr 2004; 43(6):325-335
(check this in PDF content)
15
Bugel S. Vitamin K and bone health in adult humans. Vitam Horm 2008; 78:393-416
(check this in PDF content)
16
McCann JC, Ames BN. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging? Am J Clin Nutr 2009; 90: 889–907
(check this in PDF content)
17
Kohlmeyer M, Saupe J, Shearer M, Schaefer K et al. Bone health of adult hemodialysis patients is related to vitamin K status. Kidney Int 1997; 51:1218—1221
(check this in PDF content)
18
Pilkey M, Morton R, Boffa B et al. Subclinical vitamin K deficiency in hemodialysis patients. Am J Kidney Dis 2007; 49(3):432-439
(check this in PDF content)
19
Maіyszko J, Woіczyсski S, Skrzydlewska E, Maіyszko JS et al. Vitamin K Status in Relation to Bone Metabolism in Patients with Renal Failure. Am J Nephrol 2002;22:504-508
(check this in PDF content)
20
Eastell R, Chen P, Saag G, Burshell AL et al. Bone formation markers in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate. Bone 2010; 46(4):929-934
(check this in PDF content)
21
Gilman J, Shanahan F, Cashman KD. Altered levels of biochemical indices of bone turnover and bone-related vitamins in patients with Crohn’s disease and ulcerative colitis. Aliment Pharmacol Ther 2006; 23:1007–1016
(check this in PDF content)
22
Ersoy F. Osteoporosis in the elderly with chronic kidney disease. Int Urol Nephrol 2007; 39(1):321-331
(check this in PDF content)
23
Nickolas TL, Leonard MB, Shane E. Chronic kidney disease and bone fracture: a growing concern. Kidney Int 2008; 74(6):721-731
(check this in PDF content)
24
Holden RM, Iliescu E, Morton AR, Booth SL. Vitamin K status of canadian peritoneal dialysis patients. Periton Dial Internat 2008; 28(4):415-417
(check this in PDF content)
25
Malluche HH, Faugere MC, Fanti P, Price PA. Plasma levels of bone Gla-protein reflect bone formation in patients on chronic maintenance dialysis. Kidney Int 1984; 26(6):869-874
(check this in PDF content)
26
Epstein S, Traberg H, Raja R, Poser J. Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation. J Clin Endocrinol Metab 1985; 60(6): 1253-1256
(check this in PDF content)
27
Charhon SA, Delmas PD, Malaval L, Chavassieux PM et al. Serum bone Gla-protein in renal osteodystrophy: comparison with bone histomorphometry. J Clin Endocrinol Metab 1986; 63(4): 892-897
(check this in PDF content)
28
Farrugia W, Melick R. Metabolism of osteocalcin. Calcified Tis Intern 1986; 39(4):234-238
(check this in PDF content)
29
Joffe P, Heaf G, Hyldstrup L. Osteocalcin: A non-invasive index of metabolic bone disease in patients treated by CAPD. Kidney Int 1994; 46: 838-846
(check this in PDF content)
30
Yu S, Franceschi RT, Luo M, Zhang X et al. Parathyroid hormone increases activating transcription factor 4 expression and activity in osteoblasts: requirement for osteocalcin gene expression. Endocrinology 2008; 149(4): 1960–1968
(check this in PDF content)
31
Seibel MJ, Robins SP, Bilezikian JP. Serum undercarboxylated osteocalcin and the risk of hip fracture. J Clin Endocrin Metab 1997; 82(3):717-718
(check this in PDF content)
32
Binkley N, Harke J, Krueger D, Engelke J et al. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal north american women. J Bone Min Res 2009; 24(6):983-991
(check this in PDF content)